Trump’s Plan To Peg Drug Prices to Foreign Countries Could Backfire

SmallerHealth Caregetty images 1f20yNWsxEg unsplash copy

The Great Healthcare Plan gets the big picture right. It tackles some of the everyday frustrations patients face: high costs, confusing rules, and the outsized influence of middlemen. But Congress should be careful not to let one bad idea spoil the bunch. Lawmakers would be wise to build on the plan’s strongest reforms — and leave Most Favored Nation pricing behind.

President Trump famously quipped during his run for a second term that he had “concepts of a plan” to fix health care.

That plan finally came together in January — and congressional Republicans are eager to codify its concepts into law.

Most of Mr. Trump’s “Great Healthcare Plan” is promising. It would make more medicines available over the counter, reduce out-of-pocket costs for insured patients, empower patients rather than insurance companies, and bring greater transparency to insurance pricing.

Read the entire op-ed.

Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

Scroll to Top